| Denis Chem Lab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 537536 |
NSE Symbol : - |
P/E(TTM) : 10.78 |
|
ISIN Demat : INE051G01012 |
Div & Yield% : 4.03 |
EPS(TTM) : 5.75 |
|
Book Value(₹) : 65.99 |
Market Cap(₹Cr) : 86.04 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 44.00 | 46.75 | 45.52 | 46.17 | 43.28 | 41.38 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.00 | 46.75 | 45.52 | 46.17 | 43.28 | 41.38 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.45 | 0.54 | 0.44 | 0.65 | 0.30 | 1.17 |
| Total Income | 44.45 | 47.29 | 45.96 | 46.82 | 43.58 | 42.56 |
| Total Expenditure | 40.17 | 44.21 | 39.49 | 41.91 | 38.46 | 39.33 |
| PBIDT | 4.28 | 3.08 | 6.46 | 4.91 | 5.11 | 3.23 |
| Interest | 0.11 | 0.20 | 0.22 | 0.23 | 0.19 | 0.23 |
| PBDT | 4.17 | 2.88 | 6.25 | 4.68 | 4.93 | 3.00 |
| Depreciation | 1.53 | 1.74 | 1.83 | 1.65 | 1.61 | 1.73 |
| Tax | 0.25 | 1.46 | 1.18 | 0.28 | 0.93 | 1.01 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.35 | -0.72 | -0.09 | 0.54 | -0.09 | -0.45 |
| Reported Profit After Tax | 2.05 | 0.40 | 3.32 | 2.21 | 2.48 | 0.71 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.05 | 0.40 | 3.32 | 2.21 | 2.48 | 0.71 |
| EPS (Unit Curr.) | 1.47 | 0.29 | 2.39 | 1.60 | 1.78 | 0.51 |
| EPS (Adj) (Unit Curr.) | 1.47 | 0.29 | 2.39 | 1.60 | 1.78 | 0.51 |
| Calculated EPS (Unit Curr.) | 1.47 | 0.29 | 2.39 | 1.59 | 1.78 | 0.51 |
| Calculated EPS (Adj) (Unit Curr.) | 1.47 | 0.29 | 2.39 | 1.59 | 1.78 | 0.51 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.90 | 1.15 | 9.57 | 6.38 | 7.13 | 2.04 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.90 | 1.15 | 9.57 | 6.38 | 7.13 | 2.04 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 15.00 | 0.00 | 0.00 |
| Equity | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.73 | 6.59 | 14.19 | 10.63 | 11.81 | 7.81 |
| PBDTM(%) | 9.48 | 6.16 | 13.73 | 10.14 | 11.39 | 7.25 |
| PATM(%) | 4.66 | 0.86 | 7.29 | 4.79 | 5.73 | 1.72 |
